Surgery or radiation might be used to help prevent or treat symptoms. However, the advent of trastuzumab (herceptin) has significantly changed the treatment paradigm of patients. Learn about what types of her2 positive breast cancer herceptin® (trastuzumab) treats See full safety and boxed warnings for more information. An additional nine patients (19%) experienced stable disease for six months or longer Median duration of survival without cancer progression was 4.1 months
Learn more about the different options and outcomes here.
WATCH